Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

4.620

-0.050 (-1.07%)

At close: Sep 15, 2026, 4:00 PM EDT

4.620

0.00 (0.00%)

After-hours: Sep 15, 2026, 4:15 PM EDT

Oramed Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	2	-	1.34	2.7	2.71
Revenue Growth	-	-	-	-50.42%	-0.33%	0.33%
Cost of Revenue	-	1.99	-	-	-	-
Gross Profit	-	0.01	-	1.34	2.7	2.71
Selling, General & Admin	9.79	8.72	6.46	8.14	15.66	12.58
Research & Development	4.74	6.38	6.32	8.97	27.64	27.11
Operating Expenses	14.52	15.1	12.78	17.11	43.3	39.69
Operating Income	-14.52	-15.09	-12.78	-15.77	-40.6	-36.98
Interest Expense	-	-	-0.85	-2.04	-	-
Interest & Investment Income	1.37	2.37	4.98	8.17	3.57	0.47
Currency Exchange Gain (Loss)	-0.44	-0.25	0.17	-0.12	0.18	-0.03
Other Non Operating Income (Expenses)	8.99	0.35	-0.03	-1.54	-0.01	-0.01
EBT Excluding Unusual Items	-4.61	-12.62	-8.5	-11.3	-36.86	-36.55
Gain (Loss) on Sale of Investments	224.88	87.94	-7.42	16.39	-0.81	-0.22
Pretax Income	220.28	75.32	-15.92	5.09	-37.66	-36.77
Income Tax Expense	45.41	11.31	3.18	-	0.1	-
Earnings From Continuing Operations	174.86	64.02	-19.1	5.09	-37.76	-36.77
Minority Interest in Earnings	0.01	0.03	0.04	0.44	1.2	1.76
Net Income	174.87	64.05	-19.06	5.53	-36.56	-35
Preferred Dividends & Other Adjustments	0.81	0.81	-	-	-	-
Net Income to Common	174.06	63.24	-19.06	5.53	-36.56	-35
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	41	41	41	40	39	37
Shares Outstanding (Diluted)	42	42	41	41	39	37
Shares Change	2.31%	3.84%	0.70%	4.02%	5.08%	30.36%
EPS (Basic)	4.23	1.53	-0.47	0.14	-0.94	-0.94
EPS (Diluted)	4.15	1.50	-0.48	0.14	-0.94	-0.94
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-5.22	-9.15	-8.43	-10.55	-28.41	-33.39
Free Cash Flow Per Share	-0.12	-0.22	-0.21	-0.26	-0.73	-0.90
Gross Margin	-	0.65%	-	100.00%	100.00%	100.00%
Operating Margin	-	-754.40%	-	-1176.79%	-1501.96%	-1363.50%
Profit Margin	-	3162.10%	-	412.31%	-1352.61%	-1290.71%
Free Cash Flow Margin	-	-457.70%	-	-787.24%	-1051.20%	-1231.31%
EBITDA	-14.4	-14.97	-12.59	-15.57	-40.54	-36.92
D&A For EBITDA	0.12	0.12	0.19	0.2	0.06	0.05
EBIT	-14.52	-15.09	-12.78	-15.77	-40.6	-36.98
Effective Tax Rate	20.62%	15.01%	-	-	-	-

SEC Filings: 10-K · 10-Q